Opinion|Videos|April 7, 2025
A Case Study of Elevated Lp(a) Levels and Increased ASCVD Risk
Experts discuss an example illustrating the association between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD) risk and explore how this example can inform our understanding of Lp(a) and ASCVD risk on a population level.
Advertisement
Video content above is prompted by the following:
- Dr Wong, can you offer an example illustrating the association between Lp(a) levels and ASCVD risk?
- How might Dr Wong’s example inform how we think about Lp(a) and ASCVD risk on a population level?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South
5